Overview

Comparing Intravenous and Oral Iron in Postoperative Anemia

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Postoperative anaemia are common in patients undergoing major orthopaedic surgery. The main consequence of perioperative anaemia is an increased risk of red blood cell (RBC) transfusions. Allogeneic RBC transfusion and anaemia are associated with higher postoperative mortality and morbidity. The aim of this study was to compare the efficacy of postoperative i.v. ferric carboxymaltose (FCM) and oral ferrous glycine sulphate (FS) for early improvement of postoperative anaemia after total knee arthroplasty and whether iron treatment could facilitate recovery from surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Parc de Salut Mar
Collaborator:
Vifor Pharma
Treatments:
Ferric Compounds
Glycine
Iron